Alabama Intensifies Kratom Crackdown with Statewide Cease-and-Desist Order

Alabama Intensifies Kratom Crackdown with Statewide Cease-and-Desist Order

MONTGOMERY, AL – In a significant development for the kratom industry, Alabama Attorney General Steve Marshall announced a statewide Cease-and-Desist order on March 25, 2026, targeting businesses found to be possessing or selling products containing mitragynine and/or hydroxymitragynine, the active compounds in kratom. This decisive action reaffirms Alabama's long-standing classification of kratom as a Schedule I controlled substance under state law, a status it has held since 2016.

The Attorney General's office initiated this crackdown following independent laboratory testing that confirmed the presence of kratom in various products currently available on store shelves across the state. Notably, products such as "Boujee Bliss," "Better Weather," and "Happy Hour," which were marketed for pain relief and relaxation, were found to contain kratom without any disclosure to consumers.

Why This Matters to Kratom Merchants and Consumers

This statewide enforcement action carries serious implications for both kratom merchants and consumers, particularly given the deceptive labeling practices observed.

For kratom merchants, this order serves as a critical reminder of the complex and often stringent legal landscape surrounding kratom. Businesses operating in, or shipping to, Alabama must immediately cease all sales and remove any kratom-containing products to avoid severe legal and financial penalties. Attorney General Marshall has issued a stark warning, stating that non-compliance will lead to asset seizure and forfeiture, felony prosecution, and civil liability under the Alabama Deceptive Trade Practices Act. This highlights the absolute necessity for merchants to thoroughly understand and strictly adhere to the specific regulations of every state in which they operate.

Consumers in Alabama are also directly impacted, facing the risk of unknowingly purchasing and possessing an illegal controlled substance. The Attorney General's office has cautioned that product labels may not fully disclose all ingredients, potentially exposing purchasers to adverse health events and legal consequences. State leaders and medical professionals have expressed renewed concerns about kratom's re-emergence and its potential for harmful effects, including addiction and liver damage. The public is urged to exercise caution and avoid purchasing any product suspected of containing kratom-derived compounds.

Compliance Implications and Advice for High-Risk Merchants

The Alabama crackdown underscores several vital compliance implications for the broader kratom industry, particularly for high-risk merchants.

First, the use of independent, internationally accredited lab testing by the Attorney General's office to identify kratom in deceptively labeled products sets a precedent. High-risk merchants, even in states where kratom is legal, must demand and meticulously review comprehensive Certificates of Analysis (COAs) from their suppliers for all products. These COAs must verify the accurate content of disclosed ingredients and, crucially, confirm the absence of any undisclosed or banned substances, especially in products marketed as "natural" or "herbal" remedies, which the Alabama AG noted can be misleading.

Second, this incident reinforces the patchwork nature of kratom legality across the United States. While kratom may be legal or regulated in some states, federal legality does not supersede state-level bans. Merchants must maintain real-time awareness of the legal status of kratom in every jurisdiction they serve. Ignorance of state law, or reliance on a supplier's potentially deceptive labeling, is not a viable defense against legal action.

Ultimately, regulatory compliance for high-risk kratom merchants demands proactive due diligence. This includes continuous monitoring of state and local regulations, ensuring strict adherence to specific ingredient lists, alkaloid limits, and labeling requirements in legal jurisdictions, and a complete prohibition of sales in banned states like Alabama. Transparency, rigorous third-party lab testing, and an unwavering commitment to legal compliance are paramount to navigating the evolving regulatory landscape and mitigating significant operational and legal risks.